JAMA Talks explores pharmaceutical pricing and access to drugs with entrepreneur Mark Cuban, highlighting key impacts.
JAMA and JAMA Network Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, spoke with Mark Cuban, entrepreneur and cofounder of the Mark Cuban Cost Plus Drugs Company, about pharmaceutical pricing.
No takes yet. Share an insight, caveat, or question.
Kirsten Bibbins-Domingo (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: